Chromium(VI)-induced mutagenesis in the lungs of big blue(TM) transgenic mice

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 19, Issue 3, 2000, Pages 239-249

  Cheng, L ^a   Sonntag, D M ^a   De Boer, J ^a   Dixon, K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Big Blue mouse; Glutathione; Hexavalent chromium; Mutagenesis; Mutation spectrum

Indexed keywords

BUTHIONINE SULFOXIMINE; CHROMIUM DERIVATIVE; DICHROMATE POTASSIUM; GLUTATHIONE PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DOSE TIME EFFECT RELATION; FEMALE; LUNG; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPONTANEOUS MUTATION; TRANSGENIC MOUSE;

ANIMALS; ANTIMETABOLITES; BUTHIONINE SULFOXIMINE; CARCINOGENS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE; INSTILLATION, DRUG; KIDNEY; LIVER; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENESIS; MUTAGENS; MUTATION; POTASSIUM DICHROMATE; TRACHEA;

EID: 0033856195     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Occupational and environmental cancers of the respiratory system
2. One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports
3. Carcinogen risk assessment of chromium compounds
4. Effect of calcium chromate dust, influenza virus, and 100 R whole-body X radiation on lung tumor incidence in mice
5. Experimental studies in metal carcinogenesis: Chromium, nickel, iron, arsenic
6. Causes of lung cancer
7. Studies in pulmonary carcinogenesis
8. Genetic effects of chromium compounds
9. Chromium toxicity and carcinogenesis
10. Microsomal reduction of the carcinogen chromate produces chromium(V)
11. The reduction of chromium (VI) to chromium (III) by glutathione: An intracellular redox pathway in the metabolism of the carcinogen chromate
12. Ascorbate is the principal reductant of chromium(VI) in rat liver and kidney ultrafiltrates
13. Metabolic reduction of chromium, as related to its carcinogenic properties
14. Distribution and HPLC study of chromium-51 binding sites in Chinese hamster ovary cells
15. Induction of mutagenic DNA damage by chromium(VI) and glutathione
16. Evidence for the generation of hydroxyl radicals from a chromium(V) intermediate isolated from the reaction of chromate with glutathione
17. Intracellular chromium reduction
18. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione
19. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells
20. Formation of the amino-acid-DNA complexes by hexavalent and trivalent chromium in vitro: Importance of trivalent chromium and the phosphate group
21. Mutational spectrum of chromium (VI) in human cells
22. Mutational specificity of chromium(VI) compounds in the hprt locus of Chinese hamster ovary-K1 cells
23. Mutational specificity in a shuttle vector replicating in chromium(VI)-treated mammalian cells
24. Development of a short-term in vivo mutagenesis assay: The effects of methlyation on the recovery of a lambda phage shuttle vector from transgenic mice
25. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice
26. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector
27. The use of shuttle vectors for mutation analysis in transgenic mice and rats
28. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: Applications in research and therapy
29. Transport of glutathione, as gamma-glutamylcysteinylglycyl ester, into liver and kidney
30. Multielemental analysis of human fetal tissues using inductively coupled plasma-mass spectrometry
31. A fluorometric method for determination of oxidized and reduced glutathione in tissues
32. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthaldehyde
33. An efficient laboratory protocol for the sequencing of large number of lacI mutants recovered from Big Blue transgenic animals
34. Kinetics of pulmonary cells
35. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice
36. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats
37. Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid
38. Inhaled benzene increases the frequency and length of lacI deletion mutations in lung tissues of mice
39. Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice
40. Spontaneous mutation in lacI transgenic mice: A comparison of tissues
41. Comparison of somatic mutation in a transgenic versus host locus
42. Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model
43. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: An autopsy study
44. Chromium-induced kidney disease
45. Toxicity and carcinogenicity of Cr(VI) in animal models and humans
46. Pathways of Cr (III) and Cr (VI) in the rat after intratracheal administration
47. Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo
48. Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium
49. Modification of chromium (VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes